Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 32471661 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| testing for anti-human leukocyte antigen (hla) antibodies has now become standard practice in allogeneic hematopoietic stem cell transplantation (hsct), and anti-hla antibodies (both donor specific and non-donor specific) are being identified and have many potential consequences. | |||||||
| 32552930 | HLA (HLA) | mycophenolate | NA | methotrexate | NA | unclassified | |
| NA | |||||||
| 32582592 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| minor histocompatibility (h) antigens are major histocompatibility complex (mhc)/human leukocyte antigen (hla)-bound peptides that differ between allogeneic hematopoietic stem cell transplantation (hct) recipients and their donors as a result of genetic polymorphisms. | |||||||
| 32624583 | HLA IDENTICAL (HLA-IDENTICAL) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| sixteen adult patients received a prophylactic dli at a median of 113 days (range 76-280 days) following an hla-identical, non-myeloablative allogeneic hematopoietic stem cell transplantation. | |||||||
| 32764469 | HLA (HLA) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| nk cells can exert remarkable graft-versus-leukemia (gvl) effect in hla-haploidentical hematopoietic stem cell transplantation (haplo-hsct). | |||||||
| 32788111 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| outcomes of symptomatic venous thromboembolism after haploidentical donor hematopoietic stem cell transplantation and comparison with human leukocyte antigen-identical sibling transplantation. | |||||||
| 32788111 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | venous thromboembolism | NA | NA | NA | unclassified | |
| outcomes of symptomatic venous thromboembolism after haploidentical donor hematopoietic stem cell transplantation and comparison with human leukocyte antigen-identical sibling transplantation. | |||||||
| 33159239 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | ruxolitinib | NA | cyclophosphamide | NA | unclassified | |
| NA | |||||||
| 33179442 | HLA-A (HLA-A) | hematopoietic stem cell transplantation | Korean | NA | NA | unclassified | |
| distributions of hla-a, -b, and -drb1 alleles typed by amplicon-based next generation sequencing in korean volunteer donors for unrelated hematopoietic stem cell transplantation. | |||||||
| 33179442 | HLA-DRB1 (HLA-DRB1) | hematopoietic stem cell transplantation | Korean | NA | NA | unclassified | |
| distributions of hla-a, -b, and -drb1 alleles typed by amplicon-based next generation sequencing in korean volunteer donors for unrelated hematopoietic stem cell transplantation. | |||||||
Copyright 2024